Patty Culp
AbbVie Biotherapeutics
pattyculp.jpg
Patty Culp, PhD, has worked in the biotech industry for over 10 years, developing antibody-based therapeutics to treat cancer. She received her PhD from MIT, studying early development of zebrafish, and her postdoctoral training at UCSF was in the area of translational control in Xenopus laevis. She currently works at AbbVie Biotherapeutics, leading a team of researchers in a highly matrixed organization. While in industry, Patty has co-authored a number of papers and patents and led one drug program into Phase 1 clinical studies.
